My Health - About the company
My Health is an unfunded company based in Hasselt (Belgium), founded in 2017. It operates as a Developer of microbial probiotic strains. My Health has not raised any funding yet. The company has 76 active competitors, including 18 funded and 13 that have exited. Its top competitors include companies like Novozymes, Seres Therapeutics and Infinant Health.
Company Details
Developer of microbial probiotic strains. The company focuses on the development of microbiome solutions for functional dyspepsia with DUOSPORE, and have launched a diverse portfolio to support people with various needs.
Key Metrics
Founded Year
2017
Location
Hasselt, Belgium
Stage
Unfunded
Ranked
49th among 76 active competitors
Employee Count
13 as on May 31, 2026
Sign up to download My Health's company profile
My Health's funding and investors
My Health has not raised any funding rounds yet.
My Health's founders and board of directors
Founder? Claim ProfileMy Health's employee count trend
My Health has 13 employees as of May 26. Here is My Health's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
My Health's Competitors and alternates
Top competitors of My Health include Novozymes, Seres Therapeutics and Infinant Health. Here is the list of Top 10 competitors of My Health, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of biosolutions and enzymes for multiple industries and applications of biotechnology | $9.75M | 73/100 | ||
2nd | Seres Therapeutics 2010, Cambridge (United States), Public | Developer of microbiome therapeutics to treat a wide range of diseases | $134M | 60/100 | |
3rd | Infinant Health 2011, Norwalk (United States), Series C | Microbiome-based products to improve infant immune system | $39.2M | 59/100 | |
4th | Manufactures a range of health supplements and pharmaceuticals | - | - | 59/100 | |
5th | Genome & Company 2015, Seongnam-si (South Korea), Public | Developer of microbiome-based immuno-oncology drugs | - | 55/100 | |
6th | Resbiotic 2021, Birmingham (United States), Series A | Provider of probiotic supplements to improve health | $20.6M | 55/100 | |
7th | Nextbiotix 2016, Dijon (France), Series A | Developer of probiotic for the treatment of inflammatory bowel diseases | $30.4M | 54/100 | |
8th | Oragenics 1996, Tampa (United States), Public | Developer of novel treatments for infectious diseases and oral mucositis as well as probiotics for oral health | - | 53/100 | |
9th | Provider of gut microbiome data insights, analytics, tests, and therapeutics | $10.5M | 52/100 | ||
10th | Rebiotix 2011, Roseville (United States), Acquired | Developing microbiota restoration therapy for the treatment of infectious diseases. | $29.3M | 51/100 | |
49th | Developer of microbial probiotic strains | - | - | 26/100 |
Looking for more details on My Health's competitors? Click here to see the top ones
My Health's Investments and acquisitions
My Health has made no investments or acquisitions yet.
Reports related to My Health
Here is the latest report on My Health's sector:
News related to My Health
•
Are you a Founder ?
FAQs about My Health
Explore our recently published companies
- Medinne Media - Turkey based, Unfunded company
- NeoFoxy - Unfunded company
- THUNA - Kuwait based, 2019 founded, Unfunded company
- Deborah Friend Wilson - Unfunded company
- Appzera (Opc) - Bengaluru based, Unfunded company
- Sky Fly Trucking - Columbus based, 2021 founded, Unfunded company
